Stemina Presented at the Annual Meeting of the Northland Chapter of SOT
Oct 4, 2017Developmental Toxicity Potency of Valproate Analogues in a Human Pluripotent Stem Cell-Based Assay Presented at the Annual Meeting of the Northland Chapter of the Society of Toxicology (September 2017) by Jessica Palmer, Associate Director of Toxicology Development and validation of alternative models for developmental toxicity testing is essential for reducing the number of animals used
Stemina Featured as an Innovative Madison-Area Business
Sep 27, 2017In collaboration with the Greater Madison Chamber of Commerce, the Wisconsin State Journal produced a special section to “highlight and explore innovation efforts.” Each company’s profile is written by its leader. Stemina’s CEO, Elizabeth Donley, penned our article and also graces the cover of the section. Read Stemina’s profile Explore other companies in the section
Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics
Aug 25, 2017Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.